Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Travera Inc
Endeavor Biomedicines, Inc.
Lumicell, Inc.
Ipsen
Incyte Corporation
Incyte Corporation
Merck Sharp & Dohme LLC
Incyte Corporation
PharmaMar
Ipsen
Taproot Health
Symphogen A/S
Bristol-Myers Squibb
Amphera BV
Polaris Group
Candel Therapeutics, Inc.
Xencor, Inc.
Incyte Corporation
Calithera Biosciences, Inc
AbbVie
AbbVie
Eli Lilly and Company
Novartis
Shionogi Inc.
Incyte Corporation
Epizyme, Inc.
Novartis
Bayer
Incyte Corporation
Merck Sharp & Dohme LLC
Curis, Inc.
Bayer
Novartis
GlaxoSmithKline
Bayer
Eli Lilly and Company
Virttu Biologics Limited
Novartis
Morphotek
Valerio Therapeutics
Valerio Therapeutics
Morphotek
AstraZeneca
Astellas Pharma Inc
Pfizer
Mannkind Corporation
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company